Bayer and MOMA Therapeutics have announced a new collaboration aimed at advancing precision cancer treatments. The ...

ADCs are at the forefront of cancer treatment, providing targeted therapies with promising results for lung cancer. We have ...

Antibody-drug conjugates (ADCs) represent a significant breakthrough in oncology, offering targeted treatments, for lung ...

Antibody-drug conjugates (ADCs) are transforming the landscape of cancer treatment by targeting hard-to-treat cancers with ...

Oncolytic viruses are emerging as a promising development in cancer treatment. We will have an interview with Dr. Thomas C.